Home | News | Questions remain surrounding Oxford vaccine trial pause
AstraZeneca headquarters in Sydney. Photo: NCA NewsWire/Bianca De Marchi

Questions remain surrounding Oxford vaccine trial pause

Scientists around the globe celebrated news the University of Oxford would restart the trial for its COVID-19 vaccine candidate, but some called for more transparency surrounding the pause while others backed the decision to not detail the illness that prompted it.

Please login below to view content or register for a 4 week FREE Trial.

Membership Login

Get the news delivered straight to your inbox

Receive the top stories in our weekly newsletter Sign up now